Search - tctmd.com

Displaying 1 - 20 of 550

Sort: Relevancy | Date

February 2026 Dispatch for the CV Team

News Daily News

February 2026 Dispatch for the CV Team

February 18, 2026

Oral GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis

News Daily News

Oral GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis

February 06, 2026

Weight Loss Drugs Show Promise for Secondary Prevention in PAD

News Daily News

Weight Loss Drugs Show Promise for Secondary Prevention in PAD

February 04, 2026

Nearly 150 Million US Adults Eligible for CKM Syndrome Meds

News Daily News

Nearly 150 Million US Adults Eligible for CKM Syndrome Meds

February 02, 2026

PULSAR: Globe Pulsed-Field Ablation System Performs Well in Paroxysmal AF

News Daily News

PULSAR: Globe Pulsed-Field Ablation System Performs Well in Paroxysmal AF

January 27, 2026

Heart Disease Remains Number One Killer of Americans

News Daily News

Heart Disease Remains Number One Killer of Americans

January 22, 2026

New Dietary Guidelines for Americans Get Mixed Review From Cardiology Community

News Daily News

New Dietary Guidelines for Americans Get Mixed Review From Cardiology Community

January 12, 2026

Easy Exercise Prevents Mortality in Cardio-Kidney-Metabolic Syndrome

News Daily News

Easy Exercise Prevents Mortality in Cardio-Kidney-Metabolic Syndrome

Yael L. Maxwell

January 12, 2026

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

News Daily News

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Michael O'Riordan

December 30, 2025

Year in Review: Top Prevention Stories of 2025

News Daily News

Year in Review: Top Prevention Stories of 2025

Michael O'Riordan

December 24, 2025

Remission From Prediabetes Halves CV Risk: Registry Data

News Daily News

Remission From Prediabetes Halves CV Risk: Registry Data

Yael L. Maxwell

December 19, 2025

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

News Daily News

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Michael O'Riordan

December 18, 2025

Aprocitentan Effective in CKD Patients With Resistant Hypertension: PRECISION

News Daily News

Aprocitentan Effective in CKD Patients With Resistant Hypertension: PRECISION

December 16, 2025

Rising HF Burden in the US Potentially Related to Changes in Cardiometabolic Factors

News Daily News

Rising HF Burden in the US Potentially Related to Changes in Cardiometabolic Factors

Yael L. Maxwell

December 02, 2025

Pediatric Hypertension On the Rise Globally

News Daily News

Pediatric Hypertension On the Rise Globally

November 28, 2025

Mortality and Other Adverse Events After TAVI Higher in Frailer Patients

News Daily News

Mortality and Other Adverse Events After TAVI Higher in Frailer Patients

Yael L. Maxwell

November 25, 2025

Semaglutide’s CV Effects Only Partially Tied to Weight Loss: SELECT Analysis

News Daily News

Semaglutide’s CV Effects Only Partially Tied to Weight Loss: SELECT Analysis

Yael L. Maxwell

October 24, 2025

Disparities in MCS Use for STEMI-Related Shock Seen Across the US

News Daily News

Disparities in MCS Use for STEMI-Related Shock Seen Across the US

October 21, 2025

Type 2 MI Diagnoses on the Rise, but Best Course of Action Unknown

News Daily News

Type 2 MI Diagnoses on the Rise, but Best Course of Action Unknown

October 08, 2025

Bax24: Baxdrostat Successful Again, This Time in Resistant Hypertension

News Daily News

Bax24: Baxdrostat Successful Again, This Time in Resistant Hypertension

October 07, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.